- Supported exchanges /
- ST /
- INIT.ST
Initiator Pharma A/S (INIT ST) stock market data APIs
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes IPED2015, a drug candidate which is in clinical phase 2a for the treatment of organic erectile dysfunction; IP2018, a monoamine reuptake inhibitor completed Phase IIa for the treatment of psychogenic erectile dysfunction primarily targeting the serotonin followed by the dopamine system; and IPTN2021, a Phase 1 clinical drug program targeting an orphan drug indication in severe neuropathic pain, and trigeminal neuralgia. The company also developing IP2017, a proprietary triple reuptake inhibitor; and IP2016, a preclinical development for the treatment of depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
Initiator Pharma A/S Financial Data Overview
| 6.27 | |
| 6.73 | |
| - | |
| 6.85 | |
| 5.97 | |
| 6.35-11.75 | |
| 373 M | |
| 56 158 K | |
| 0 | |
| 0.567 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Initiator Pharma A/S Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -42 534 752
- Earnings Per Share -0.34
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Initiator Pharma A/S Earnings via APIs
- Latest Release 2024-11-15
- EPS/Forecast NaN
Get Initiator Pharma A/S End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
